logo
Does GB virus C ('hepatitis G virus') threaten the safety of our blood supply?
Policies and procedures for the establishment of an allogeneic blood stem cell collection programme
Identification of HLA class II antigens as the targets of effector clones which may cause transfusion-associated graft-versus-host disease
Comparison of two blood cell separators in collecting peripheral blood stem cell components
Blood spillage during salvage
Effects on complement activation of a new continuous autotransfusion system
Length of survival after perioperative transfusion
The presence of free infectious cytomegalovirus (CMV) in the plasma of donated CMV-seropositive blood and platelets
A comparison of monoclonal antibody immobilization of platelet antigen (MAIPA) and immunobead methods for detection of GPIIb/IIIa antiplatelet antibodies in immune thrombocytopenic purpura
Comparison of Fyb status as determined serologically and genetically
Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists Consensus Conference on Anti-D Prophylaxis 7 & 8 April 1997
THROMBOTIC EPISODES FOLLOWING TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN: A REPORT OF THREE CASES AND A REVIEW OF THE LITERATURE.
A COMPARATIVE STUDY OF RHESUS PREVENTION PROGRAMMES IN AUSTRALIAN, CANADIAN AND SCOTTISH CENTRES
TEACHING HOSPITAL TRANSFUSION AUDIT PROGRAMME
FFP AND PLATELET AUDIT OF PUBLIC HOSPITAL BLOOD BANKS
AUTOLOGOUS BLOOD COLLECTION: SURVEY OF AUSTRALASIAN PRACTICE
REDUCTION IN INAPPROPRIATE BLOOD TRANSFUSIONS BY THE INTRODUCTION OF GUIDELINES AND PROSPECTIVE MONITORING.
ABO BLOOD GROUP ANTIGENS AND HORMONES: FACTORS WHICH INFLUENCE VON WILLEBRAND ANTIGEN (vWFAg) AND FACTOR VIII (FVIII) CONCENTRATION.
ANALYSIS OF VON WILLEBRAND FACTOR OVER THE MANUFACTURE OF PLASMA DERIVED FACTOR VIII CONCENTRATES.
IN VITRO AND IN VIVO CHARACTERISTICS OF THROMBOGENIC POTENTIAL IN COAGULATION FACTOR IX CONCENTRATES FOR THE TREATMENT OF HAEMOPHILIA B.
MonoFIX®, A HIGH PURITY FACTOR IX CONCENTRATE, IN PATIENTS WITH HAEMOPHILIA B.
"EFFECT OF HIGH CITRATE CONCENTRATION (20-36mM) ON THE PLASMA LEVEL OF FACTOR VIIIc"
A HIGH PURITY ANTITHROMBIN III CONCENTRATE FOR THE TREATMENT OF ANTITHROMBIN III DEFICIENCY
ANTENATAL PLATELET ANTIBODY TESTING- 3 YEARS ON
THE PREDICTION OF SEVERITY OF HAEMOLYTIC DISEASE OF THE NEWBORN BY ANTIBODY TITRATION - CAN IT BE IMPROVED?
FOETOMATERNAL HAEMORRHAGE IN Rh D INCOMPATIBLE PREGNANCY: EVALUATION OF A FLOW CYTOMETRIC TEST.
ANTENATAL SCREENING FOR HPA-la BY FLOW CYTOMETRY.
ABSOLUTE FLOW CYTOMETRIC QUANTITATION OF RESIDUAL NUCLEATED BLOOD CELLS IN LEUKODEPLETED BLOOD PRODUCTS.
LEUCOCYTE CONTAMINATION OF FRESH FROZEN PLASMA
PLASMA RECOVERY WITH THE 'SECOND SPIN' TECHNIQUE: PROBLEMS SOLVED.
ANTI-COMPLIMENTARY ACTIVITY OF IMMUNOGLOBULIN AGGREGATES IN HEAT-TREATED INTRAVENOUS IMMUNOGLOBULIN SOLUTIONS
BACTERIAL EXPRESSION OF AN ANTI-RH(D) SINGLE CHAIN FV FRAGMENT
USE OF BLOOD PRODUCTS IN WESTERN AUSTRALIA
EVIDENCE FOR A PLASMA FACTOR ESSENTIAL FOR PLATELET MAINTENANCE
INCREASED PLASMA YIELD FROM PLATELET PRODUCTION: IMPLEMENTATION AND OUTCOMES.
NANOFILTRATION OF A THROMBIN CONCENTRATE USING VIRESOLVE 70 MEMBRANES
DONOR IN FOCUS: A STUDY OF THE QUEENSLAND POPULATION THAT IS ELIGIBLE, AVAILABLE AND WILLING TO DONATE BLOOD.
DONOR IN FOCUS: REENGINEERING OPERATIONS OF THE DONATION FACILITY AT RED CROSS BLOOD TRANSFUSION SERVICE QUEENSLAND (RCBTSQ), HEADQUARTERS.
HEPATITIS G IN BLOOD DONORS?
DEVELOPMENT OF TRANSFUSION GUIDELINES
Current Risks of Transfusion-Transmissible Diseases
SAFETY OF THE CANADIAN BLOOD SUPPLY
Gene Therapy
Gene therapy in Bleeding Disorders:
HUMAN BLOOD PROTEINS FROM TRANSGENIC PLANTS AND ANIMALS.
Peripheral Stem Cell Collection and Manipulation
Leukocytes: the Trojan horse in platelet concentrates.
Limiting Donor Exposure in Pediatric Patients
PERIOPERATIVE HEMODILUTION IN THE PEDIATRIC PATIENT
COINHERITANCE OF TYPE 1 (1) AND TYPE 2N (2N) VON WILLEBRAND DISEASE (vWD).
USE OF IMPLANTABLE MICROCAPSULES TO DELIVER FACTOR IX IN MICE: A MODEL FOR GENE THERAPY OF HEMOPHILIA B
MATRIX-DEGRADING METALLOPROTEINASES ARE SECRETED INTO THE HEMATOPOIETIC MICRO-ENVIRONMENT.
EVALUATION OF THE HEMOSTATIC EFFICACY OF TWO NOVEL AGENTS USING THE THROMBOCYTOPENIC RABBIT MODEL.
Procoagulant Activity in Heparin Induced Thrombocytopenia
THE EFFECTS OF COLLOID PLASMA VOLUME EXPANDERS ADDED TO CARDIOPULMONARY BYPASS CIRCUIT PRIME
DETECTION OF RHESUS SPECIFIC RED CELL AUTOANTIBODIES USING PHAGE DISPLAY.
REACTIVITY OF ANTI-D REAGENTS WITH WEAK D RED CELLS.
RED CELL TRANSFUSION PATTERNS IN 45 HOSPITALS.
HEPATITIS C VIRUS (HCV) TARGETED LOOKBACK PROGRAM: PRELIMINARY RESULTS.
ERROR RATES IN AUTOLOGOUS DONATIONS IN CANADA.
THE MODULATION OF CLOTTING FACTOR Xa FUNCTION BY AUTOPROTEOLYSIS AND PLASMIN
Thrombopoietin: Biological and Clinical Studies
PLATELET SUBSTITUTES
PLATELET STRUCTURE AND FUNCTION.
Short Title: Human HPA-1a specific Fab fragments from phage display.
PLATELET ALLOIMMUNIZATION: Modelling of human alloimmunization in Severe Combined Immune Deficient Mice
Krever Issues
ACCREDITATION OF HOSPITAL BLOOD BANKS, THE HOSPITAL PERSPECTIVE
DEVELOPMENT OF A FEDERAL REGULATORY PROGRAM FOR HOSPITAL BLOOD ESTABLISHMENTS
TRANSFUSION OF "OLD" BLOOD IS ASSOCIATED WITH INCREASED MORTALITY IN SEPTIC RATS
THE CATALYTIC ACTIVITY OF THE PROTO-ONCOGENIC SRC PROTEIN TYROSINE KINASE IS UP-REGULATED BY THE PROTEIN TYROSINE PHOSPHATASE PTP1C
ANTIBODIES TO EPSTEIN-BARR VIRUS (EBV) CROSS-REACT WITH PLATELET ANTIGENS IN CHILDREN WITH EBV-ASSOCIATED IMMUNE THROMBOCYTOPENIC PURPURA.
RESTRICTED USE OF CATIONIC GERMLINE VH GENE SEGMENTS IN HUMAN RH(D) BLOOD GROUP ANTIBODIES.
A FUNCTIONAL CHIMERIC HIRUDIN-ALBUMIN FUSION PROTEIN WITH GREATLY DECREASED CLEARANCE IN VIVO.
EVALUATION OF PLATELET STORAGE LESION BY VON WILLEBRAND FACTOR(VWF) BEAD ASSAY.
DIFFERENTIAL INTERACTIONS OF SpA AND HIV-1 gp120 SUPERANTIGENS WITH HUMAN IgM.
CHARACTERIZATION OF A GROWTH INHIBITORY CYTOKINE ACTIVE ON B-CELL HYBRIDOMAS.
IDENTIFICATION OF HEPATITIS C VIRUS E1 ANTIBODIES IN PATIENTS & BLOOD DONORS.
EPIDEMIOLOGY OF HEPATITIS C VIRUS (HCV) INFECTION IN BLOOD DONORS.
TRACEBACKS ON HCV POSITIVE RECIPIENTS IDENTIFIED BY THE BRITISH COLUMBIA CHILDREN'S AND WOMEN'S HOSPITAL RECIPIENT NOTIFICATION PILOT STUDY
RESTRICTED USE OF SPLENIC IMMUNOGLOBULIN(Ig) VARIABLE REGION (V) GENES IN AUTO IMMUNE HEMOLYTIC ANEMIA (AIHA).
C-2 CERAMIDE INHIBITS PATHWAYS DOWNSTREAM FROM PHOSPHOLIPASE C IN HUMAN NEUTROPHILS.
PROCOAGULANT MECHANISMS ON HERPESVIRIDAE
HLA ANTIBODY SCREENING OF FEMALE DONORS WITH A HISTORY OF CHILDBIRTH.
IDENTIFICATION OF A NEW DRB1*01 ALLELE (DRB1*01022) by CANTYPE ASSAY
CANTYPE: HIGH RESOLUTION HLA-DR TYPING USING A NEW REVERSE HYBRIDIZATION ASSAY.
EFFECT OF ARA-C ON THE HUMAN-LEUKEMIA SCID MODEL AND ON SCID HEMATOPOIESIS
ENDOGENOUS EXPRESSION AND BINDING OF ANNEXINS TO HUMAN PLATELETS.
PLATELET TRANSFUSION REACTIONS - RESULTS OF A THREE-MONTH SURVEY.
A METHOD FOR EARLY PREDICTION OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
FIBRINOGEN RECOVERIES AFFECTED BY VARIATIONS IN CRYOPRECIPITATE PREPARATION.
PERFORMANCE OF THREE MICRO SYSTEMS FOR DETECTION OF RED CELL ANTIBODIES
USING EMLA® TO REDUCE THE PAIN OF PLASMA PHERESIS.
EVALUATION OF DONOR SKIN DISINFECTION METHODS.
METHODOLOGICAL DEVELOPMENT FOR DOSE-RESPONSE ANALYSIS OF THE HEMOGLOBIN ALLOSTERIC MODIFIER, RSR13, IN RATS.
STRATEGIES TO REDUCE DONOR BLOOD EXPOSURE IN THE NEONATAL INTENSIVE CARE UNIT (NICU)
SMALL VOLUME RED CELL TRANSFUSIONS IN A NEONATAL INTENSIVE CARE UNIT - RESULTS OF UTILIZATION REVIEW.
TRANSFUSIONS IN A HEMATOLOGY/ONCOLOGY SERVICE - RESULTS OF UTILIZATION REVIEW.
EVIDENCE FOR IN VIVO THROMBIN GENERATION FOLLOWING THE TRANSFUSION OF BLOOD FROM A POST-OPERATIVE DRAINAGE DEVICE.
TRANSFUSION PRACTICE IN A CANADIAN HOSPITAL COMPARED WITH PRACTICE IN EUROPE.
EVALUATION OF A CLIENT-ADMINISTERED LAPTOP COMPUTERIZED QUESTIONNAIRE TO DETECT RISK FACTORS FOR BLOOD-BORNE DISEASES IN DONOR POPULATIONS IN CANADA.
DECREASING TRANSFUSION OF BLOOD PRODUCTS IN A TERTIARY CARE CENTRE.
AUTOLOGOUS PREDONATION IN CARDIAC SURGICAL PATIENTS.
COMMUNICATING TRANSFUSION RISKS TO THE PUBLIC: THE PALING PERSPECTIVE SCALE.
ANALYSIS OF THE Rh (D) STATUS OF A FETUS AT RISK FOR Rh (D) HEMOLYTIC DISEASE FROM A MOTHER WITH ANTI-Rh(D) AND A DISCREPANT DNA BASED Rh(D) GENOTYPE.
AN INTERNATIONAL COMPARISON OF THE INCIDENCE OF AIDS ASSOCIATED WITH BLOOD AND BLOOD PRODUCTS.
EXCHANGE MUTAGENESIS OF THE THROMBIN-INHIBITORY SERPINS, ANTITHROMBIN AND HEPARIN COFACTOR II.
Guidelines for pre-transfusion compatability procedures
Guidelines for pre-transfusion compatability procedures
Are guidelines for use of gamma irradiation for the prevention of transfusion-associated graft-versus-host disease adequate for newborns?
Are guidelines for use of gamma irradiation for the prevention of transfusion-associated graft-versus-host disease adequate for newborns?
Transfusionsmedizin 1995/96.
ANNOUNCEMENTS